Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
- 1 August 2004
- Vol. 22 (23-24) , 2993-3003
- https://doi.org/10.1016/j.vaccine.2004.02.021
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Vaccine, 2003
- Influenza A Virus M2Ion Channel Activity Is Essential for Efficient Replication in Tissue CultureJournal of Virology, 2002
- The value of a database in surveillance and vaccine selectionInternational Congress Series, 2001
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humansPublished by Elsevier ,2001
- The Impact of Influenza Epidemics on HospitalizationsThe Journal of Infectious Diseases, 2000
- Ion selectivity and activation of the M2 ion channel of influenza virusBiophysical Journal, 1996
- Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 proteinVaccine, 1995
- A simplified method for determination of peptide-protein molar ratios using amino acid analysisJournal of Immunological Methods, 1992
- Acidic derivatives of homocysteine thiolactone: utility as anionic linkersBioconjugate Chemistry, 1992
- Tissue sulfhydryl groupsArchives of Biochemistry and Biophysics, 1959